20:56 , Dec 14, 2018 |  BioCentury  |  Finance

Mission: Mainstream

Mission Bio Inc. plans to deploy its $30 million series B round to expand the applications and client base for its single-cell DNA analysis platform. Agilent Technologies Inc. (NYSE:A), Cota Capital, Laboratory Corp. of America...
19:09 , Dec 14, 2018 |  BC Week In Review  |  Financial News

Mission Bio raises $30M series B to expand Tapestri’s reach

Precision genomics company Mission Bio Inc. (South San Francisco, Calif.) raised $30 million on Dec. 13 in an untranched series B round from Agilent Technologies (NYSE:A), Cota Capital, Laboratory Corp. of America Holdings (NYSE:LH), LAM...
17:00 , Dec 13, 2018 |  BC Extra  |  Financial News

Mission Bio raises $30M series B to expand Tapestri’s reach

Precision genomics company Mission Bio Inc. (South San Francisco, Calif.) raised $30 million in an untranched series B round from Agilent Technologies (NYSE:A), Cota Capital, Laboratory Corp. of America Holdings (NYSE:LH), LAM Research Capital and...
19:27 , Sep 28, 2018 |  BC Week In Review  |  Company News

Agilent acquires tools company Acea to expand China footprint

Agilent Technologies Inc. (NYSE:A) acquired cell analysis tools company Acea Biosciences Inc. (San Diego, Calif.) for $250 million. Agilent said the acquisition will expand the company's capabilities in China, where Acea has a large manufacturing...
21:08 , Aug 2, 2018 |  BC Extra  |  Company News

Management tracks: Omeros, EdiGene

Omeros Corp. (NASDAQ:OMER) hired Eckhard Leifke as CMO and VP of clinical development. He was global project head/VP of early project and external opportunities - cardiovascular and metabolism and global head/VP of late-stage development diabetes...
22:18 , Aug 1, 2018 |  BC Extra  |  Company News

Management tracks: Hologic, Tricidia

Hologic Inc. (NASDAQ:HOLX) said Bob McMahon has departed as CFO to become CFO at Agilent Technologies Inc. (NYSE:A). The diagnostics company promoted Chief Accounting Officer Karleen Oberton to CFO. Metabolic acidosis play Tricida Inc. (NASDAQ:TCDA)...
19:30 , Jun 15, 2018 |  BC Week In Review  |  Clinical News

FDA approves Keytruda in cervical cancer, PMBCL

Merck & Co. Inc. (NYSE:MRK) said FDA granted accelerated approval to Keytruda pembrolizumab to treat recurrent or metastatic cervical cancer with disease progression on or after chemotherapy in patients whose tumors express PD-L1, with a...
22:05 , Apr 25, 2018 |  BC Extra  |  Company News

Management tracks: Urovant, Cue

Urology company Urovant Sciences, a subsidiary of Roivant Sciences GmbH (Basel, Switzerland), hired Cornelia Haag-Molkenteller as CMO, Michael McFadden as chief commercial officer, Bryan Smith as general counsel and Christine Ocampo as SVP and chief...
01:09 , Feb 16, 2018 |  BC Innovations  |  Strategy

Pfizer’s chemistry machine

With the goal of creating a step-change in the optimization of small molecules in discovery research, Pfizer Inc. has built a continuous flow machine that rapidly tests thousands of chemical reactions using submilligram quantities of...
22:29 , Jun 15, 2017 |  BC Extra  |  Company News

Twist, BioBricks launching open gene forum

Twist Bioscience Corp. (San Francisco, Calif.) and BioBricks Foundation (San Francisco, Calif.) partnered to create an open online forum for researchers to suggest and vote on genes for manufacture. BioBricks will pay for synthesis of...